Alpha Dna Investment Management LLC Novo Nordisk A S Transaction History
Alpha Dna Investment Management LLC
- $7.64 Billion
- Q1 2025
Shares
1 transactions
Others Institutions Holding NVO
# of Institutions
1,768Shares Held
329MCall Options Held
11.3MPut Options Held
15.5M-
Jennison Associates LLC18.8MShares$1.28 Billion0.93% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$1.01 Billion0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$845 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$840 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$810 Million0.36% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $154B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...